Global Alpha Thalassemia Market Growth 2018-2023

October 2018 | 136 pages | ID: G80817DF2B6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.
Over the next five years, LPI(LP Information) projects that Alpha Thalassemia will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Alpha Thalassemia market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Alpha Thalassemia market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Iron Chelating Drugs
• Gene Therapy

Segmentation by application:

• Hospitals
• Private clinics
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Bluebird Bio
• Novartis
• Kiadis Pharma
• Acceleron Pharma
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Alpha Thalassemia consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Alpha Thalassemia market by identifying its various subsegments.
• Focuses on the key global Alpha Thalassemia manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Alpha Thalassemia with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Alpha Thalassemia submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Alpha Thalassemia Consumption 2013-2023
  2.1.2 Alpha Thalassemia Consumption CAGR by Region
2.2 Alpha Thalassemia Segment by Type
  2.2.1 Iron Chelating Drugs
  2.2.2 Gene Therapy
2.3 Alpha Thalassemia Consumption by Type
  2.3.1 Global Alpha Thalassemia Consumption Market Share by Type (2013-2018)
  2.3.2 Global Alpha Thalassemia Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Alpha Thalassemia Sale Price by Type (2013-2018)
2.4 Alpha Thalassemia Segment by Application
  2.4.1 Hospitals
  2.4.2 Private clinics
  2.4.3 Other
2.5 Alpha Thalassemia Consumption by Application
  2.5.1 Global Alpha Thalassemia Consumption Market Share by Application (2013-2018)
  2.5.2 Global Alpha Thalassemia Value and Market Share by Application (2013-2018)
  2.5.3 Global Alpha Thalassemia Sale Price by Application (2013-2018)

3 GLOBAL ALPHA THALASSEMIA BY PLAYERS

3.1 Global Alpha Thalassemia Sales Market Share by Players
  3.1.1 Global Alpha Thalassemia Sales by Players (2016-2018)
  3.1.2 Global Alpha Thalassemia Sales Market Share by Players (2016-2018)
3.2 Global Alpha Thalassemia Revenue Market Share by Players
  3.2.1 Global Alpha Thalassemia Revenue by Players (2016-2018)
  3.2.2 Global Alpha Thalassemia Revenue Market Share by Players (2016-2018)
3.3 Global Alpha Thalassemia Sale Price by Players
3.4 Global Alpha Thalassemia Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Alpha Thalassemia Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Alpha Thalassemia Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ALPHA THALASSEMIA BY REGIONS

4.1 Alpha Thalassemia by Regions
  4.1.1 Global Alpha Thalassemia Consumption by Regions
  4.1.2 Global Alpha Thalassemia Value by Regions
4.2 Americas Alpha Thalassemia Consumption Growth
4.3 APAC Alpha Thalassemia Consumption Growth
4.4 Europe Alpha Thalassemia Consumption Growth
4.5 Middle East & Africa Alpha Thalassemia Consumption Growth

5 AMERICAS

5.1 Americas Alpha Thalassemia Consumption by Countries
  5.1.1 Americas Alpha Thalassemia Consumption by Countries (2013-2018)
  5.1.2 Americas Alpha Thalassemia Value by Countries (2013-2018)
5.2 Americas Alpha Thalassemia Consumption by Type
5.3 Americas Alpha Thalassemia Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Alpha Thalassemia Consumption by Countries
  6.1.1 APAC Alpha Thalassemia Consumption by Countries (2013-2018)
  6.1.2 APAC Alpha Thalassemia Value by Countries (2013-2018)
6.2 APAC Alpha Thalassemia Consumption by Type
6.3 APAC Alpha Thalassemia Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Alpha Thalassemia by Countries
  7.1.1 Europe Alpha Thalassemia Consumption by Countries (2013-2018)
  7.1.2 Europe Alpha Thalassemia Value by Countries (2013-2018)
7.2 Europe Alpha Thalassemia Consumption by Type
7.3 Europe Alpha Thalassemia Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Alpha Thalassemia by Countries
  8.1.1 Middle East & Africa Alpha Thalassemia Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Alpha Thalassemia Value by Countries (2013-2018)
8.2 Middle East & Africa Alpha Thalassemia Consumption by Type
8.3 Middle East & Africa Alpha Thalassemia Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Alpha Thalassemia Distributors
10.3 Alpha Thalassemia Customer

11 GLOBAL ALPHA THALASSEMIA MARKET FORECAST

11.1 Global Alpha Thalassemia Consumption Forecast (2018-2023)
11.2 Global Alpha Thalassemia Forecast by Regions
  11.2.1 Global Alpha Thalassemia Forecast by Regions (2018-2023)
  11.2.2 Global Alpha Thalassemia Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Alpha Thalassemia Forecast by Type
11.8 Global Alpha Thalassemia Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Bluebird Bio
  12.1.1 Company Details
  12.1.2 Alpha Thalassemia Product Offered
  12.1.3 Bluebird Bio Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Bluebird Bio News
12.2 Novartis
  12.2.1 Company Details
  12.2.2 Alpha Thalassemia Product Offered
  12.2.3 Novartis Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Novartis News
12.3 Kiadis Pharma
  12.3.1 Company Details
  12.3.2 Alpha Thalassemia Product Offered
  12.3.3 Kiadis Pharma Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Kiadis Pharma News
12.4 Acceleron Pharma
  12.4.1 Company Details
  12.4.2 Alpha Thalassemia Product Offered
  12.4.3 Acceleron Pharma Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Acceleron Pharma News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alpha Thalassemia
Table Product Specifications of Alpha Thalassemia
Figure Alpha Thalassemia Report Years Considered
Figure Market Research Methodology
Figure Global Alpha Thalassemia Consumption Growth Rate 2013-2023 (K Units)
Figure Global Alpha Thalassemia Value Growth Rate 2013-2023 ($ Millions)
Table Alpha Thalassemia Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Iron Chelating Drugs
Table Major Players of Iron Chelating Drugs
Figure Product Picture of Gene Therapy
Table Major Players of Gene Therapy
Table Global Consumption Sales by Type (2013-2018)
Table Global Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Figure Global Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Table Global Alpha Thalassemia Revenue by Type (2013-2018) ($ million)
Table Global Alpha Thalassemia Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Alpha Thalassemia Value Market Share by Type (2013-2018)
Table Global Alpha Thalassemia Sale Price by Type (2013-2018)
Figure Alpha Thalassemia Consumed in Hospitals
Figure Global Alpha Thalassemia Market: Hospitals (2013-2018) (K Units)
Figure Global Alpha Thalassemia Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Alpha Thalassemia Consumed in Private clinics
Figure Global Alpha Thalassemia Market: Private clinics (2013-2018) (K Units)
Figure Global Alpha Thalassemia Market: Private clinics (2013-2018) ($ Millions)
Figure Global Private clinics YoY Growth ($ Millions)
Figure Alpha Thalassemia Consumed in Other
Figure Global Alpha Thalassemia Market: Other (2013-2018) (K Units)
Figure Global Alpha Thalassemia Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Figure Global Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Table Global Alpha Thalassemia Value by Application (2013-2018)
Table Global Alpha Thalassemia Value Market Share by Application (2013-2018)
Figure Global Alpha Thalassemia Value Market Share by Application (2013-2018)
Table Global Alpha Thalassemia Sale Price by Application (2013-2018)
Table Global Alpha Thalassemia Sales by Players (2016-2018) (K Units)
Table Global Alpha Thalassemia Sales Market Share by Players (2016-2018)
Figure Global Alpha Thalassemia Sales Market Share by Players in 2016
Figure Global Alpha Thalassemia Sales Market Share by Players in 2017
Table Global Alpha Thalassemia Revenue by Players (2016-2018) ($ Millions)
Table Global Alpha Thalassemia Revenue Market Share by Players (2016-2018)
Figure Global Alpha Thalassemia Revenue Market Share by Players in 2016
Figure Global Alpha Thalassemia Revenue Market Share by Players in 2017
Table Global Alpha Thalassemia Sale Price by Players (2016-2018)
Figure Global Alpha Thalassemia Sale Price by Players in 2017
Table Global Alpha Thalassemia Manufacturing Base Distribution and Sales Area by Players
Table Players Alpha Thalassemia Products Offered
Table Alpha Thalassemia Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Alpha Thalassemia Consumption by Regions 2013-2018 (K Units)
Table Global Alpha Thalassemia Consumption Market Share by Regions 2013-2018
Figure Global Alpha Thalassemia Consumption Market Share by Regions 2013-2018
Table Global Alpha Thalassemia Value by Regions 2013-2018 ($ Millions)
Table Global Alpha Thalassemia Value Market Share by Regions 2013-2018
Figure Global Alpha Thalassemia Value Market Share by Regions 2013-2018
Figure Americas Alpha Thalassemia Consumption 2013-2018 (K Units)
Figure Americas Alpha Thalassemia Value 2013-2018 ($ Millions)
Figure APAC Alpha Thalassemia Consumption 2013-2018 (K Units)
Figure APAC Alpha Thalassemia Value 2013-2018 ($ Millions)
Figure Europe Alpha Thalassemia Consumption 2013-2018 (K Units)
Figure Europe Alpha Thalassemia Value 2013-2018 ($ Millions)
Figure Middle East & Africa Alpha Thalassemia Consumption 2013-2018 (K Units)
Figure Middle East & Africa Alpha Thalassemia Value 2013-2018 ($ Millions)
Table Americas Alpha Thalassemia Consumption by Countries (2013-2018) (K Units)
Table Americas Alpha Thalassemia Consumption Market Share by Countries (2013-2018)
Figure Americas Alpha Thalassemia Consumption Market Share by Countries in 2017
Table Americas Alpha Thalassemia Value by Countries (2013-2018) ($ Millions)
Table Americas Alpha Thalassemia Value Market Share by Countries (2013-2018)
Figure Americas Alpha Thalassemia Value Market Share by Countries in 2017
Table Americas Alpha Thalassemia Consumption by Type (2013-2018) (K Units)
Table Americas Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Figure Americas Alpha Thalassemia Consumption Market Share by Type in 2017
Table Americas Alpha Thalassemia Consumption by Application (2013-2018) (K Units)
Table Americas Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Figure Americas Alpha Thalassemia Consumption Market Share by Application in 2017
Figure United States Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure United States Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Canada Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Canada Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Mexico Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Mexico Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Table APAC Alpha Thalassemia Consumption by Countries (2013-2018) (K Units)
Table APAC Alpha Thalassemia Consumption Market Share by Countries (2013-2018)
Figure APAC Alpha Thalassemia Consumption Market Share by Countries in 2017
Table APAC Alpha Thalassemia Value by Countries (2013-2018) ($ Millions)
Table APAC Alpha Thalassemia Value Market Share by Countries (2013-2018)
Figure APAC Alpha Thalassemia Value Market Share by Countries in 2017
Table APAC Alpha Thalassemia Consumption by Type (2013-2018) (K Units)
Table APAC Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Figure APAC Alpha Thalassemia Consumption Market Share by Type in 2017
Table APAC Alpha Thalassemia Consumption by Application (2013-2018) (K Units)
Table APAC Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Figure APAC Alpha Thalassemia Consumption Market Share by Application in 2017
Figure China Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure China Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Japan Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Japan Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Korea Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Korea Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure India Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure India Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Australia Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Australia Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Table Europe Alpha Thalassemia Consumption by Countries (2013-2018) (K Units)
Table Europe Alpha Thalassemia Consumption Market Share by Countries (2013-2018)
Figure Europe Alpha Thalassemia Consumption Market Share by Countries in 2017
Table Europe Alpha Thalassemia Value by Countries (2013-2018) ($ Millions)
Table Europe Alpha Thalassemia Value Market Share by Countries (2013-2018)
Figure Europe Alpha Thalassemia Value Market Share by Countries in 2017
Table Europe Alpha Thalassemia Consumption by Type (2013-2018) (K Units)
Table Europe Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Figure Europe Alpha Thalassemia Consumption Market Share by Type in 2017
Table Europe Alpha Thalassemia Consumption by Application (2013-2018) (K Units)
Table Europe Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Figure Europe Alpha Thalassemia Consumption Market Share by Application in 2017
Figure Germany Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Germany Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure France Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure France Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure UK Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure UK Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Italy Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Italy Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Russia Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Russia Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Spain Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Spain Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Alpha Thalassemia Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Alpha Thalassemia Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Alpha Thalassemia Consumption Market Share by Countries in 2017
Table Middle East & Africa Alpha Thalassemia Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Alpha Thalassemia Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Alpha Thalassemia Value Market Share by Countries in 2017
Table Middle East & Africa Alpha Thalassemia Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Alpha Thalassemia Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Alpha Thalassemia Consumption Market Share by Type in 2017
Table Middle East & Africa Alpha Thalassemia Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Alpha Thalassemia Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Alpha Thalassemia Consumption Market Share by Application in 2017
Figure Egypt Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Egypt Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure South Africa Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure South Africa Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Israel Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Israel Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure Turkey Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure Turkey Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Alpha Thalassemia Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Alpha Thalassemia Value Growth 2013-2018 ($ Millions)
Table Alpha Thalassemia Distributors List
Table Alpha Thalassemia Customer List
Figure Global Alpha Thalassemia Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Alpha Thalassemia Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Alpha Thalassemia Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Alpha Thalassemia Consumption Market Forecast by Regions
Table Global Alpha Thalassemia Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Alpha Thalassemia Value Market Share Forecast by Regions
Figure Americas Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Americas Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure APAC Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure APAC Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Europe Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Europe Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Middle East & Africa Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Middle East & Africa Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure United States Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure United States Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Canada Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Canada Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Mexico Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Mexico Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Brazil Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Brazil Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure China Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure China Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Japan Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Japan Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Korea Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Korea Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Southeast Asia Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Southeast Asia Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure India Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure India Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Australia Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Australia Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Germany Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Germany Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure France Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure France Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure UK Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure UK Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Italy Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Italy Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Russia Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Russia Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Spain Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Spain Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Egypt Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Egypt Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure South Africa Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure South Africa Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Israel Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Israel Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure Turkey Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure Turkey Alpha Thalassemia Value 2018-2023 ($ Millions)
Figure GCC Countries Alpha Thalassemia Consumption 2018-2023 (K Units)
Figure GCC Countries Alpha Thalassemia Value 2018-2023 ($ Millions)
Table Global Alpha Thalassemia Consumption Forecast by Type (2018-2023) (K Units)
Table Global Alpha Thalassemia Consumption Market Share Forecast by Type (2018-2023)
Table Global Alpha Thalassemia Value Forecast by Type (2018-2023) ($ Millions)
Table Global Alpha Thalassemia Value Market Share Forecast by Type (2018-2023)
Table Global Alpha Thalassemia Consumption Forecast by Application (2018-2023) (K Units)
Table Global Alpha Thalassemia Consumption Market Share Forecast by Application (2018-2023)
Table Global Alpha Thalassemia Value Forecast by Application (2018-2023) ($ Millions)
Table Global Alpha Thalassemia Value Market Share Forecast by Application (2018-2023)
Table Bluebird Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bluebird Bio Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bluebird Bio Alpha Thalassemia Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Alpha Thalassemia Market Share (2016-2018)
Table Kiadis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kiadis Pharma Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kiadis Pharma Alpha Thalassemia Market Share (2016-2018)
Table Acceleron Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acceleron Pharma Alpha Thalassemia Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Acceleron Pharma Alpha Thalassemia Market Share (2016-2018)